ID24524A - Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen - Google Patents

Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen

Info

Publication number
ID24524A
ID24524A IDW20000958A ID20000958A ID24524A ID 24524 A ID24524 A ID 24524A ID W20000958 A IDW20000958 A ID W20000958A ID 20000958 A ID20000958 A ID 20000958A ID 24524 A ID24524 A ID 24524A
Authority
ID
Indonesia
Prior art keywords
reductives
phosphereilase
glicogen
aldosa
obstacles
Prior art date
Application number
IDW20000958A
Other languages
English (en)
Indonesian (id)
Inventor
Banavara Lakshman Mylari
Dennis Jay Hoover
Bernard Hulin
Judith Lee Treadway
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24524A publication Critical patent/ID24524A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Superheterodyne Receivers (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Noise Elimination (AREA)
IDW20000958A 1997-11-21 1998-11-02 Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen ID24524A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6636597P 1997-11-21 1997-11-21

Publications (1)

Publication Number Publication Date
ID24524A true ID24524A (id) 2000-07-20

Family

ID=22069038

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000958A ID24524A (id) 1997-11-21 1998-11-02 Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen

Country Status (38)

Country Link
EP (1) EP1032424B9 (fr)
JP (1) JP2002504478A (fr)
KR (2) KR20010032304A (fr)
CN (1) CN1279617A (fr)
AP (1) AP911A (fr)
AR (1) AR016423A1 (fr)
AT (1) ATE205403T1 (fr)
AU (1) AU733304B2 (fr)
BG (1) BG104435A (fr)
BR (1) BR9814698A (fr)
CA (1) CA2310069A1 (fr)
DE (1) DE69801680T2 (fr)
DK (1) DK1032424T3 (fr)
DZ (1) DZ2656A1 (fr)
EA (1) EA002365B1 (fr)
ES (1) ES2161548T3 (fr)
GR (1) GR3037071T3 (fr)
GT (1) GT199800166A (fr)
HR (1) HRP20000327A2 (fr)
HU (1) HUP0100272A3 (fr)
ID (1) ID24524A (fr)
IL (1) IL135713A0 (fr)
IS (1) IS5453A (fr)
MA (1) MA26568A1 (fr)
NO (1) NO20002164L (fr)
OA (1) OA11379A (fr)
PA (1) PA8462301A1 (fr)
PE (1) PE135399A1 (fr)
PL (1) PL340643A1 (fr)
PT (1) PT1032424E (fr)
SK (1) SK7222000A3 (fr)
TN (1) TNSN98211A1 (fr)
TR (1) TR200001451T2 (fr)
UA (1) UA57811C2 (fr)
UY (1) UY25258A1 (fr)
WO (1) WO1999026659A1 (fr)
YU (1) YU30700A (fr)
ZA (1) ZA9810636B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536410A (ja) * 1999-02-12 2002-10-29 ノボ ノルディスク アクティーゼルスカブ 肥満の治療又は予防もしくは食欲の調節を目的とした薬学的組成物の製造におけるピロリジン誘導体の使用
EP1743655B1 (fr) 2000-01-21 2014-06-25 Novartis AG Combinaisons à base d'inhibiteurs de DPP-IV et d'antidiabetiques
CO5271699A1 (es) 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
US6570013B2 (en) 2000-02-16 2003-05-27 Pfizer Inc Salts of zopolrestat
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
IL144507A0 (en) * 2000-07-31 2002-05-23 Pfizer Prod Inc Use of glycogen phosphorylase inhibitors to inhibit tumor growth
WO2002098429A1 (fr) * 2001-06-07 2002-12-12 Pfizer Products Inc. Formes salines du zopolrestat, a savoir ethanolamine, diethanolamine ou triethanolamine
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US7057046B2 (en) 2002-05-20 2006-06-06 Bristol-Myers Squibb Company Lactam glycogen phosphorylase inhibitors and method of use
CA2392486A1 (fr) 2002-07-05 2002-12-08 Duchesnay Inc. Forme posologique pharmaceutique portant une inscription pour les femmes enceintes
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
SG134333A1 (en) 2003-11-12 2007-08-29 Phenomix Corp Heterocyclic boronic acid compounds
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
EP1778220A1 (fr) 2004-07-12 2007-05-02 Phenomix Corporation Composes cyano contraints
US7223786B2 (en) 2004-11-15 2007-05-29 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
US7226942B2 (en) 2004-11-15 2007-06-05 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006053274A2 (fr) 2004-11-15 2006-05-18 Bristol-Myers Squibb Company Derives de tetraline 2-amino-1-fonctionnalises et inhibiteurs correspondants de glycogene phosphorylase
WO2006055463A2 (fr) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company Derives de 2-amino-3-tetraline fonctionnalisee et inhibiteurs de la glycogene phosphorylase associes
US20060235028A1 (en) 2005-04-14 2006-10-19 Li James J Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
PT1931350E (pt) 2005-09-14 2014-02-12 Takeda Pharmaceutical Administração de inibidores de dipeptidil peptidase
EP2046753A2 (fr) 2006-07-06 2009-04-15 Brystol-Myers Squibb Company Inhibiteurs de type i de la 11-bêta hydroxystéroïde déshydrogénase pyridone/hydroxypyridine
US7727978B2 (en) 2006-08-24 2010-06-01 Bristol-Myers Squibb Company Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
EP2142551B1 (fr) 2007-04-17 2015-10-14 Bristol-Myers Squibb Company Composés HÉTÉROCYCLIQUEs CONDENSÉS comme INHIBITEURS DE la 11-béta-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE I
ES2388315T3 (es) 2007-05-04 2012-10-11 Bristol-Myers Squibb Company Agonistas [6,5]-bicíclicos de receptores GPR119 acoplados a la proteína G
US7910583B2 (en) 2007-05-04 2011-03-22 Bristol-Myers Squibb Company [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
EA016595B1 (ru) 2007-07-17 2012-06-29 Бристол-Маерс Сквибб Компани Способ модулирования рецептора gpr119, сопряженного с g-белком, и используемые при этом соединения
TW201006821A (en) 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
WO2011041293A1 (fr) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Dérivés pyrazolo [1, 5—a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose
PL2531501T3 (pl) 2010-02-03 2014-05-30 Takeda Pharmaceuticals Co Inhibitory kinazy 1 regulującej sygnał apoptotyczny
SG184168A1 (en) 2010-04-08 2012-10-30 Bristol Myers Squibb Co Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
CN102971313A (zh) 2010-04-14 2013-03-13 百时美施贵宝公司 新颖的葡糖激酶激活剂及其使用方法
US8729084B2 (en) 2010-05-06 2014-05-20 Bristol-Myers Squibb Company Benzofuranyl analogues as GPR119 modulators
US8940716B2 (en) 2010-05-06 2015-01-27 Bristol-Myers Squibb Company Bicyclic heteroaryl compounds as GPR119 modulators
ES2555927T3 (es) 2011-01-20 2016-01-11 Bionevia Pharmaceuticals Inc. Composiciones de liberación modificada de epalrestat o un derivado del mismo y métodos para el uso de las mismas
WO2013173198A1 (fr) 2012-05-16 2013-11-21 Bristol-Myers Squibb Company Analogues de pyrimidinylpipéridinyloxypyridone en tant que modulateurs de gpr119
WO2015061272A1 (fr) 2013-10-22 2015-04-30 Bristol-Myers Squibb Company Inhibiteurs de triazolopyridine 11-bêta hydroxystéroïde déshydrogénase de type 1 à marquage isotopique
JP7072557B2 (ja) 2016-07-22 2022-05-20 ブリストル－マイヤーズ スクイブ カンパニー グルコキナーゼ活性化剤およびその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4825448A (en) * 1986-08-07 1989-04-25 International Mobile Machines Corporation Subscriber unit for wireless digital telephone system
DE3889326D1 (de) * 1988-05-27 1994-06-01 Itt Ind Gmbh Deutsche Korrekturschaltung für ein digitales Quadratur-Signalpaar.
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
FI974437A7 (fi) * 1995-06-06 1997-12-05 Pfizer Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
DE69523182T2 (de) * 1995-06-06 2002-02-07 Pfizer Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren

Also Published As

Publication number Publication date
WO1999026659A1 (fr) 1999-06-03
ATE205403T1 (de) 2001-09-15
YU30700A (sh) 2002-12-10
PT1032424E (pt) 2001-12-28
MA26568A1 (fr) 2004-12-20
BG104435A (bg) 2001-01-31
EP1032424B9 (fr) 2004-10-06
HUP0100272A2 (hu) 2001-06-28
EP1032424A1 (fr) 2000-09-06
PL340643A1 (en) 2001-02-12
EP1032424B1 (fr) 2001-09-12
OA11379A (en) 2004-01-28
NO20002164L (no) 2000-07-19
NO20002164D0 (no) 2000-04-27
AU9555898A (en) 1999-06-15
TNSN98211A1 (fr) 2005-03-15
GR3037071T3 (en) 2002-01-31
PE135399A1 (es) 2000-01-15
IL135713A0 (en) 2001-05-20
KR20010032304A (ko) 2001-04-16
CA2310069A1 (fr) 1999-06-03
CN1279617A (zh) 2001-01-10
AU733304B2 (en) 2001-05-10
AP9801401A0 (en) 1998-12-31
HUP0100272A3 (en) 2002-11-28
DE69801680T2 (de) 2002-02-07
KR20010032300A (ko) 2001-04-16
PA8462301A1 (es) 2000-05-24
DZ2656A1 (fr) 2003-03-22
DE69801680D1 (de) 2001-10-18
SK7222000A3 (en) 2001-09-11
IS5453A (is) 2000-04-14
AP911A (en) 2000-12-07
AR016423A1 (es) 2001-07-04
ES2161548T3 (es) 2001-12-01
DK1032424T3 (da) 2001-11-19
EA002365B1 (ru) 2002-04-25
KR100661214B1 (ko) 2006-12-26
TR200001451T2 (tr) 2002-06-21
JP2002504478A (ja) 2002-02-12
EA200000433A1 (ru) 2000-12-25
GT199800166A (es) 2000-04-19
HRP20000327A2 (en) 2001-02-28
UY25258A1 (es) 2000-12-29
UA57811C2 (uk) 2003-07-15
ZA9810636B (en) 2000-05-22
BR9814698A (pt) 2000-10-03

Similar Documents

Publication Publication Date Title
ID24524A (id) Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen
ID22807A (id) Hasil derifat 1-aril dan piridilpirazol untuk pestisida
ID19422A (id) Piridina dan bifenil tersubstitusi
ID27859A (id) Tampon dan metoda pembuatannya
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID19385A (id) Adesif termosetting dan metoda pembuatannya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID20463A (id) Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID28114A (id) Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait
ID26331A (id) Metode dan sistem untuk pita-pita kelipatan penarik
ID19588A (id) Ester dan amida heterosiklik
ID22708A (id) Perangkai gen dan metodanya
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID24695A (id) Metode dan konstruksi basemen anti lembab
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID28025A (id) Metode pembuatan aminonitril dan diamina
ID24463A (id) Metode meningkatkan ketersediaan hayati feksofenadin dan turunan-turunannya
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
ID21847A (id) Komposisi insektisida dan metoda penggunaannya
ID21862A (id) Komposisi-komposisi insektisida dan mitisida